Core Viewpoint - The company, UBTECH Robotics (stock code: 09880), has announced the acquisition of a 7% stake in Wuxi Youqi from Tianqi Automation Engineering for a total consideration of RMB 130 million, which will increase its ownership in Wuxi Youqi to approximately 41.49% [1] Group 1: Acquisition Details - The acquisition is subject to the terms and conditions of the share transfer agreement [1] - Post-acquisition, the company will maintain over 50% voting rights in Wuxi Youqi, which will continue to operate as a non-wholly-owned subsidiary [1] Group 2: Business Focus of Wuxi Youqi - Wuxi Youqi specializes in providing logistics robot products and services to well-known domestic new energy vehicle companies, tire industry clients, and global customers [1] - The company focuses on five core industries: automotive, tire, 3C electronics, batteries, and e-commerce [1] Group 3: Strategic Rationale - The acquisition is based on the company's assessment of the future development prospects of the embodied intelligent humanoid robot industry [1] - Increasing the stake in Wuxi Youqi is expected to facilitate the strategic development of large-scale deployment of embodied intelligent humanoid robots in industrial scenarios, aligning with the company's overall strategic planning [1]

Core Viewpoint - The company, UBTECH Robotics (09880.HK), has announced the acquisition of a 7% stake in Wuxi Youqi from Tianqi Automation Engineering for a total consideration of RMB 130 million, which includes tax [1] Group 1 - The board of directors approved the share transfer agreement on November 25, 2025 [1] - Upon completion of the acquisition, the company will hold approximately 41.4906% of Wuxi Youqi's shares [1] - The company will maintain over 50% voting rights in Wuxi Youqi, which will continue to be a non-wholly owned subsidiary of the company [1]

（於中華人民共和國註冊成立之股份有限公司） （股份代號：9880） 將於2025年12月10日（星期三）舉行之2025年第六次臨時股東會（或其任何續會）的 代表委任表格 UBTECH ROBOTICS CORP LTD 深 圳 市 優 必 選 科 技 股 份 有 限 公 司 為本人╱ 吾等代表 （附註4） ，代表本人╱ 吾等出席本公司定於2025年12月10日（星期三）下午四時正於中國深圳市南山區 學苑大道1001號南山智園C1棟25樓JIMU會議室召開及舉行的2025年第六次臨時股東會（「臨時股東會」）（或其任何續 會），並於該會議（或其任何續會）上代表本人╱ 吾等，依照下列指示就下列決議案投票，如無作出指示，則由本人╱ 吾 等的代表酌情決定投票。除文義另有所指外，本表格所用詞彙與本公司日期為2025年11月25日的通函所界定者具有 相同涵義。 | | （附註5） 普通決議案 | （附註6） 贊成 | 反對 | （附註6） | （附註6） 棄權 | | --- | --- | --- | --- | --- | --- | | 1. | 審議及批准關於本公司收購無錫優奇7%股權的決議案。 | | | | | ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本通告的內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不對因本通告全部或任何部分內容而產生或因依賴該等內容而引致的 任 何 損 失 承 擔 任 何 責 任。 UBTECH ROBOTICS CORP LTD 深 圳 市 優 必 選 科 技 股 份 有 限 公 司 （於中華人民共和國註冊成立之股份有限公司） （股份代號：9880） 2025年第六次臨時股東會通告 茲通告 深 圳 市 優 必 選 科 技 股 份 有 限 公 司（「本公司」）將 於2025年12月10日 （星 期 三）下 午 四 時 正 於 中 國 深 圳 市 南 山 區 學 苑 大 道1001號南山智園C1棟 25樓JIMU會議室召開及舉行2025年 第 六 次 臨 時 股 東 會（「臨時股東會」）， 藉 以 審 議 及 酌 情 批 准 以 下 決 議 案： 周 劍 深 圳，2025年11月25日 附 註： 委 任 受 委 代 表 的 文 據 須 由 股 東 簽 署 或 由 其 以 書 面 正 式 授 權 的 代 表 簽 署。倘 ...

閣下如對本通函任何方面或 閣下應採取之行動有任何疑問，應諮詢股票經紀或其他註冊證券交 易商、銀行經理、律師、專業會計師或其他專業顧問。 閣下如已售出或轉讓名下所有深圳市優必選科技股份有限公司之股份，應立即將本通函及隨附代 表委任表格送交買主或承讓人，或經手買賣或轉讓之銀行、股票經紀或其他代理商，以便轉交買 主或承讓人。 香港交易及結算所有限公司及香港聯合交易所有限公司對本通函的內容概不負責，對其準確性或 完整性亦不發表任何聲明，並明確表示，概不就因本通函之全部或任何部分內容而產生或因倚賴 該等內容而引致的任何損失承擔任何責任。 此乃要件 請即處理 UBTECH ROBOTICS CORP LTD 深 圳 市 優 必 選 科 技 股 份 有 限 公 司 （於中華人民共和國註冊成立之股份有限公司） （股份代號：9880） (1) 有關收購無錫優奇7%股權的關連交易； (2) 銀行信貸安排； (3) 擔保安排； 及 2025年第六次臨時股東會通告 除另有指明者外，本封面所用詞彙與本通函所界定者具有相同涵義。 本公司將於2025年12月10日（星期三）下午四時正於中國深圳市南山區學苑大道1001號南山智園C1 棟25 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不就因本公告之全部或任何部分內容而產生或因倚賴該等內容而引致 的 任 何 損 失 承 擔 任 何 責 任。 UBTECH ROBOTICS CORP LTD 深 圳 市 優 必 選 科 技 股 份 有 限 公 司 （於中華人民共和國註冊成立之股份有限公司） （股份代號：9880） 公 告 (1) 收購無錫優奇7%股 權 的 關 連 交 易； (2) 銀 行 信 貸 安 排； 及 (3) 擔保安排 (1) 收購事項 2025年11月25日，董 事 會 批 准 本 公 司（作 為 買 方）與 天 奇 自 動 化 工 程 （作 為 賣 方）及 無 錫 優 奇（作 為 目 標 公 司）簽 訂 股 份 轉 讓 協 議，據 此， 本公司同意以人民幣130,130,000元（含 稅）的 代 價 收 購 天 奇 自 動 化 工 程持有的無錫優奇7%股權，惟須遵守股份轉讓協議的條款及條件。 完 成 後，我 們 將 直 接 持 有 無 錫 優 奇 約41.4 ...

Core Viewpoint - The market's reaction to the recent share placement by UBTECH deviated from the typical negative sentiment associated with such actions in the Hong Kong stock market, indicating a structural shift in investor perception towards the company and the humanoid robotics industry [1][3][10]. Group 1: Market Reaction - The share placement involved 31.468 million new H-shares at a price of HKD 98.80, representing an 11.39% discount from the previous closing price of HKD 111.50 [1]. - Contrary to expectations, the stock price remained stable and even rebounded after an initial dip, suggesting that investors are reassessing their valuation logic [1][3]. - The inclusion of UBTECH in the MSCI China Index indicates that international funds are not avoiding the stock, reflecting a change in risk appetite among investors [1][3]. Group 2: Industry Sentiment Shift - The industry has undergone three emotional phases: a high expectation premium period, a value correction phase, and the current rational observation phase where investors focus on delivery capabilities and cost reduction [5][6]. - UBTECH is seen as a leader in the industry, having transitioned from a focus on technological superiority to cost and delivery leadership, which aligns with the market's evolving valuation criteria [9][10]. Group 3: Implications of the Share Placement - The share placement is not merely a financial necessity but is positioned within the broader context of the commercialization window for humanoid robots, aiming to accelerate delivery capabilities [12][14]. - The funds raised, approximately HKD 3.109 billion, will primarily be used for investments in supply chain integration and industry consolidation, signaling a proactive approach to scaling production [12][14]. - UBTECH's Walker S2 has reached mass production, with a target of over 1,000 units in 2025 and plans to scale to 10,000 units by 2027, emphasizing the importance of supply chain readiness for commercial success [14][19]. Group 4: Commercialization Acceleration - The company has secured over RMB 1.1 billion in cumulative orders for the Walker series, with a significant portion expected to be delivered within the year, indicating a rapid acceleration in commercialization [16][19]. - The demand for humanoid robots spans various sectors, including automotive manufacturing and smart logistics, showcasing a diversified market approach [19][20]. - UBTECH's production capacity is currently operating at full throttle, with a monthly output of 300 units, and the company is achieving high yield rates for the Walker S2 [19][20]. Group 5: Financial and Technological Advancements - UBTECH's financial performance is improving, with a 27.5% year-on-year revenue growth in the first half of 2025, alongside a narrowing loss, indicating a positive trend in financial health [21][22]. - The company has invested heavily in R&D, with expenditures reaching RMB 218 million, representing 35.1% of revenue, focusing on optimizing mechanical structures and control algorithms [21][22]. - UBTECH has established a robust supply chain and technological capabilities, including proprietary advancements in servo motors and AI systems, which are critical for meeting industrial demands [22][23].

| H 股 | | | | | --- | --- | --- | --- | | 董事 | | | | | 一周劍先生(2) | | 17.71% | 83 | | 一熊友軍先生(3) | | 1.20% | | | 一夏佐全先生(4) | | 4.22% | l તે | | 承配人(2) | | | 31 | | 其他H股公眾持有人 | | | | | 持有的H股 | 292,108,446 | 61.90% | 292 | | | 401,267,396 | 85.03% | 432 | | | | 公告显示，董事认为，本次配售事项旨在整合上下游供应链，巩固及加强公司在人形机器人产业链的链主地位，从而强化公司在工业制造应用场景的战略布 局，抓住人形机器人落地工业制造应用场景的历史性机遇，提升公司的核心竞争力、技术实力、销售收入及盈利能力。 作为"人形机器人第一股"，优必选主要从事智能服务机器人及智能服务机器人解决方案的设计、生产、商业化、销售及营销以及研发，公司的产品在不同程 度上配备了感知、交互、分析及处理人类指令及外部环境(如建图、温度测量及人脸识别)的智能功能，范围涵盖消费级机器人及电器，针对教 ...

Group 1 - The core announcement from the company is the issuance of 31.468 million new H-shares at a price of HKD 98.80 per share, representing an approximate discount of 11.39% from the previous closing price of HKD 111.50 [1] - The estimated total proceeds from the placement are approximately HKD 3.109 billion, with a net amount of about HKD 3.056 billion, which will primarily be used for investments or acquisitions in the value chain of the group's business [1] - The company aims to strengthen its position in the humanoid robotics industry by integrating upstream and downstream supply chains, enhancing its strategic layout in industrial manufacturing applications [1] Group 2 - The company has recently achieved significant milestones, including winning a contract for a humanoid robot data collection and testing center project in Guangxi, valued at HKD 264 million, with expected delivery in December [1] - The Walker S2 humanoid robot has commenced mass production, with hundreds deployed in key sectors such as automotive manufacturing and smart logistics, contributing to a total order value of HKD 1.1 billion for the year 2025 [2] - The company has been included in the MSCI China Index, indicating recognition of its market value and growth potential, with significant trading volume on the Hong Kong stock market [2]

Group 1 - The core announcement from the company is the issuance of 31.468 million new H-shares at a price of HKD 98.80 per share, representing an approximate discount of 11.39% from the closing price of HKD 111.50 on November 24, 2025 [1] - The estimated total proceeds from the placement are approximately HKD 3.109 billion, with a net amount of about HKD 3.056 billion, of which around 75% will be used for investments or acquisitions in the upstream or downstream targets within the business value chain [1] - The company aims to strengthen its position in the humanoid robot industry chain and enhance its strategic layout in industrial manufacturing applications through this placement [1] Group 2 - The company has recently achieved significant milestones, including winning a contract for a humanoid robot data collection and testing center project in Guangxi, valued at HKD 264 million, with delivery expected in December [1] - The Walker S2 humanoid robot has commenced mass production, with hundreds deployed in key sectors such as automotive manufacturing and smart logistics, contributing to a total order value of HKD 1.1 billion for the year 2025 [2] - The company has been included in the MSCI China Index, indicating recognition of its market value and growth potential, with significant trading volume observed on the Hong Kong stock market [2]